The company has commercial products available in a number of countries, including Pennsaid
2%, sold in the US by Horizon Pharma plc, and available for partnering in certain other territories around the world.
Horizon Pharma plc , a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, today announced that the United States District Court for the District of New Jersey upheld the validity of Horizon Pharma's patent covering PENNSAID
(diclofenac sodium topical solution) 2% w/w, which Actavis Laboratories UT, Inc.
Effective immediately, Ledger will assume additional operational responsibilities and lead the company's initiative to diversify its revenue streams by out-licensing global rights for its lead product, Pennsaid
2% and by acquiring complementary products or businesses.
Horizon said the deal leverages rheumatology infrastructure and a 41-person sales force currently promoting Rayos and Pennsaid
2% to rheumatologists.
therapy for osteoarthritis of the knee: a systematic review and meta-analysis of randomized controlled trials.
Similarly, Pfizer markets Feldene; Tillomed Laboratories makes Tiloket; and Pennsaid
is produced by Nuvo Research.
15) Topical pain treatment creams, such as Voltaren gel and Pennsaid
, are sometimes effective as well.
Other new product launches during FY2010 include the Mallinckrodt TaperGuard and TaperGuard Evac endotracheal tubes, which incorporate a taper-shaped cuff designed to reduce the chances of foreign material entering the respiratory tract; the EEATM Hemorrhoid & Prolapse Stapler Set, designed to facilitate dilation, purse-string placement, tissue incorporation and stapling/resection; the Puritan Bennett 560 ventilator, a portable homecare device; DuraSeal spine sealant, a synthetic hydrogel that is prepared in minutes and sets in seconds; and Pennsaid
, a topical non-steroidal anti-inflammatory drug that contains dimethyl sulfoxide.
Diclofenac gel 1% has been approved for osteoarthritis of the knee, hand, and other superficial joints, and Pennsaid
has been approved for osteoarthritis of the knee.
The arbitration arose as a result of a contract Provalis signed with Dimethaid in January 2001 to distribute its osteoarthritis pain medication Pennsaid
in the UK.
The group said the arbitration it started against Dimethaid International Inc following the North American company's termination of the Pennsaid
distribution agreement had been decided in Provalis' favour.
M2 EQUITYBITES-October 18, 2016-Nuvo Pharmaceuticals to launch placebo controlled Phase 3 trial of Pennsaid
2% for treating acute ankle sprains upon German approval